Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Ibuprofen for Pain in Oral Lichen Planus
NCT03509675Phase 3Completed
- Sponsor
- University of Washington
- Start
- Apr 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ibuprofen in oral lichen planus (OLP) and oral lichenoid mucositis (OLM) (2 arms), sponsored by University of Washington. Primary endpoint: Self-reported Pain Scores Using 100mm Visual Analog Scale at Day 7. Started Apr 2018; status: completed.
02
Drugs
ibuprofen
03
Conditions
oral lichen planus (OLP)oral lichenoid mucositis (OLM)
Beyond the preview
Go deeper on NCT03509675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03509675.